Collagenase in the Treatment of Cellulite
Phase 2
- Conditions
- Cellulite
- Registration Number
- NCT00261144
- Lead Sponsor
- Stony Brook University
- Brief Summary
The purpose of this study is to determine if collagenase injection will reduce or eliminate the appearance of cellulite of the thigh.
- Detailed Description
This is an open label study of collagenase injection therapy for reduction and/or elimination of cellulite of the posterolateral thighs.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- 10 x 10 cm area of cellulite of the posterolateral thigh(s)
Exclusion Criteria
- any chronic, serious or uncontrolled medical condition
- inability to conform to study visits (12-15 per year)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Reduction and/or elimination of cellulite in the posterolateral thigh 6 months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways does collagenase target in the extracellular matrix to reduce thigh cellulite in NCT00261144?
How does collagenase injection therapy compare to retinoids or laser treatments for cellulite in clinical efficacy?
Which biomarkers, such as collagen density or fibrosis markers, predict response to collagenase in NCT00261144?
What are the safety profiles and management strategies for adverse events from collagenase injections in cellulite trials?
Are there combination therapies involving collagenase and hyaluronidase for cellulite treatment in Phase 2 studies by Stony Brook University?
Trial Locations
- Locations (1)
Dept. Orthopaedics, SUNY Stony Brook
🇺🇸Stony Brook, New York, United States
Dept. Orthopaedics, SUNY Stony Brook🇺🇸Stony Brook, New York, United StatesMarie A Badalamente, PhDPrincipal InvestigatorGail TrocchioContact631 444 2215Gail.Trocchio@stonybrookmedicine.eduAlexander B Dagum, MDPrincipal Investigator